CRNA Circio Holding ASA

OSL · NO · Healthcare · Biotechnology · circio.com

11.76NOK+4.63%Mkt Cap: 319.87M $P/E: —Today

Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three cli…

Headline	Source	Time
Older
Circio Holding ASA: Registration of share capital increase following private placement of approximately NOK 200 million	finansavisen.no	Sep 22
Circio Holding ASA: Ex. right to participate in potential subsequent offering today	Finansavisen	Sep 15
Circio Holding ASA: Ex. right to participate in potential subsequent offering today	Finansavisen	Sep 15
CIRCIO: INNGÅR FORSKNINGSSAMARBEID MED FULL CIRCLES THERAPEUTICS	Finansavisen	Aug 26
Circio lokker investorer med rabatt og klinisk håp	IInvestornytt	May 26
I en lab med hemmelig plassering driver årets store børsrakett forskning som prises til over 1,8 mrd.	Dagens Næringsliv	Apr 18
Circio Holding: Øker shorten i børsrakett	Finansavisen	Apr 16
Er Circio neste milliardoppkjøp?	IInvestornytt	Feb 27

CRNA Circio Holding ASA

Industry Peers